Paratek Pharmaceuticals Inc.
PRTK
Market Cap$0
Close$
$4.05
81.6% upside
Current Fair Value
81.6% upsideUndervalued by 81.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $215.64 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.11 |
| Beta | 0.0 |
| Outstanding Shares | 57,322,358 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | -0.0 |
| Price to Sales | 0.74 |
| Price to Book Ratio | -0.56 |
| Enterprise Value to Revenue | 1.22 |
| Enterprise Value to EBIT | -4.84 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 1.2 |
| Debt to Equity | -1.28 |
Revenue Sources
No data
ESG Score
No data
About Paratek Pharmaceuticals Inc.
CEO: Evan Loh